MedTrace Logo

Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion

NCT06542653 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 258

Last updated 2024-12-27

No results posted yet for this study

Summary

Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients.

Conditions

  • Coronary Atheroscleroses

Interventions

PROCEDURE

PCI

successful percutaneous coronary intervention (PCI) in Coronary chronic total occlusions (CTOs) patients

DRUG

OMT

optimal medical therapy (OMT) in CTO patients, such as aspirin 1td, ACEI/ARB 1td, β blocker 1td, statin 1td.

Sponsors & Collaborators

  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Leilei Chen · The First Affiliated Hospital with Nanjing Medical University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-17
Primary Completion
2024-09-17
Completion
2025-09-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06542653 on ClinicalTrials.gov